Ilske Oschlies

8.5k total citations
87 papers, 2.1k citations indexed

About

Ilske Oschlies is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Ilske Oschlies has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pathology and Forensic Medicine, 36 papers in Oncology and 25 papers in Neurology. Recurrent topics in Ilske Oschlies's work include Lymphoma Diagnosis and Treatment (68 papers), Viral-associated cancers and disorders (28 papers) and CNS Lymphoma Diagnosis and Treatment (23 papers). Ilske Oschlies is often cited by papers focused on Lymphoma Diagnosis and Treatment (68 papers), Viral-associated cancers and disorders (28 papers) and CNS Lymphoma Diagnosis and Treatment (23 papers). Ilske Oschlies collaborates with scholars based in Germany, Austria and Switzerland. Ilske Oschlies's co-authors include Wolfram Klapper, Alfred Reiter, Birgit Burkhardt, Martin Zimmermann, Felix Niggli, Martin Zimmermann, Wilhelm Woessmann, Reiner Siebert, Martin Schrappe and Reza Parwaresch and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Ilske Oschlies

83 papers receiving 2.1k citations

Peers

Ilske Oschlies
Pauline Brice France
Monica Tani Italy
Rémy Gressin France
Patricia Aoun United States
Liliana Devizzi Italy
Natividad Neri Mexico
Gerardo Musuraca Italy
Theresa Marafioti Germany
P. Solal-Céligny France
C. Portlock United States
Pauline Brice France
Ilske Oschlies
Citations per year, relative to Ilske Oschlies Ilske Oschlies (= 1×) peers Pauline Brice

Countries citing papers authored by Ilske Oschlies

Since Specialization
Citations

This map shows the geographic impact of Ilske Oschlies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilske Oschlies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilske Oschlies more than expected).

Fields of papers citing papers by Ilske Oschlies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilske Oschlies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilske Oschlies. The network helps show where Ilske Oschlies may publish in the future.

Co-authorship network of co-authors of Ilske Oschlies

This figure shows the co-authorship network connecting the top 25 collaborators of Ilske Oschlies. A scholar is included among the top collaborators of Ilske Oschlies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilske Oschlies. Ilske Oschlies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oschlies, Ilske, Julia Richter, Fernando Chahud, et al.. (2025). Extramedullary plasmacytoma in children is a genetically distinct localized neoplasia curable by surgical resection. Blood Advances. 9(15). 3909–3918. 1 indexed citations
2.
Müller, Stephanie, Claudia Sopalla, Claudia Lanvers‐Kaminsky, et al.. (2024). Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcome. Blood. 144(13). 1412–1417. 1 indexed citations
3.
Richter, Julia, et al.. (2023). CD27 / CD70 pathway activation in primary cutaneous CD4 + small/medium T‐cell lymphoproliferative disorder. The Journal of Pathology. 262(2). 189–197. 1 indexed citations
4.
Au-Yeung, Rex, Laura Padilla, Martin Zimmermann, et al.. (2022). Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma. Leukemia. 37(2). 488–491. 3 indexed citations
5.
6.
Au-Yeung, Rex, Julia Richter, Ingram Iaccarino, et al.. (2021). Molecular features of non‐anaplastic peripheral T‐cell lymphoma in children and adolescents. Pediatric Blood & Cancer. 68(11). e29285–e29285. 10 indexed citations
7.
Richter, Julia, Katharina John, Annette M. Staiger, et al.. (2021). Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. British Journal of Haematology. 196(3). 681–689. 16 indexed citations
8.
Croci, Giorgio Alberto, Rex Au-Yeung, Sarah Reinke, et al.. (2021). SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status. Annals of Oncology. 32(11). 1400–1409. 14 indexed citations
9.
Woessmann, Wilhelm, Martin Zimmermann, Andrea Meinhardt, et al.. (2020). Progressive or Relapsed Burkitt Lymphoma or Leukemia in Children and Adolescents after BFM-type First-line Therapy. Blood. 135(14). 1124–1132. 30 indexed citations
10.
Au-Yeung, Rex, Laura Padilla, Martin Zimmermann, et al.. (2020). Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of the NHL‐BFM group. British Journal of Haematology. 190(5). 753–763. 41 indexed citations
11.
Klapper, Wolfram, et al.. (2019). Hämatologische Neoplasien als Differenzialdiagnosen von Weichgewebstumoren. Der Pathologe. 40(4). 412–421. 2 indexed citations
12.
Reinke, Sarah, Julia Richter, Falko Fend, et al.. (2018). Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma—a feasibility study using full slide staining. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 473(3). 341–349. 3 indexed citations
13.
Макарова, О. В., Ilske Oschlies, Stephanie Müller, et al.. (2017). Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma. British Journal of Haematology. 182(5). 735–739. 9 indexed citations
14.
Rohde, Marius, Bettina R. Bonn, Martin Zimmermann, et al.. (2017). Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols. Haematologica. 102(6). 1091–1098. 32 indexed citations
15.
Henkenberens, Christoph, Anke Franzke, Peter Raab, et al.. (2014). Primary EBV-positive Hodgkin’s lymphoma of the CNS under azathioprine treatment. Strahlentherapie und Onkologie. 190(9). 847–852. 12 indexed citations
16.
Абрамов, Д. С., Ilske Oschlies, Martin Zimmermann, et al.. (2013). Expression of CD8 is associated with non-common type morphology and outcome in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Haematologica. 98(10). 1547–1553. 11 indexed citations
17.
Eiz‐Vesper, Britta, Cornelia Henke‐Gendo, Jana Diestelhorst, et al.. (2012). EBV-Specific T-Cell Immunity in Pediatric Solid Organ Graft Recipients With Posttransplantation Lymphoproliferative Disease. Transplantation. 95(1). 247–255. 20 indexed citations
18.
Lamant, Laurence, Keith McCarthy, Emanuele S. G. d'Amore, et al.. (2011). Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study. Journal of Clinical Oncology. 29(35). 4669–4676. 98 indexed citations
19.
Oschlies, Ilske, Birgit Burkhardt, Catherine Chassagne‐Clément, et al.. (2011). Diagnosis and Immunophenotype of 188 Pediatric Lymphoblastic Lymphomas Treated Within a Randomized Prospective Trial. The American Journal of Surgical Pathology. 35(6). 836–844. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pauline Brice Breakdown of academic impact, for papers by Monica Tani Breakdown of academic impact, for papers by Rémy Gressin Breakdown of academic impact, for papers by Patricia Aoun Breakdown of academic impact, for papers by Liliana Devizzi Breakdown of academic impact, for papers by Natividad Neri Breakdown of academic impact, for papers by Gerardo Musuraca Breakdown of academic impact, for papers by Theresa Marafioti Breakdown of academic impact, for papers by P. Solal-Céligny Breakdown of academic impact, for papers by C. Portlock
Rankless by CCL
2026